AstraZeneca (AZN 174.22, -15.07, -8.0%) is sharply lower after a drug in its pipeline misses its primary endpoint in a clinical trial.
.
Meta Platforms (META 587.74, -15.38, -2.6%) will place AI chip into production in September as it aims to double computing capacity, according to Reuters.
PepsiCo (PEP 140.00, -2.49, -2.1%) beat EPS expectations by $0.02, reported revenues in-line, and reaffirmed FY26 guidance.
SK Hynix’s (SKHY) U.S. listing is more than 7 times oversubscribed, according to Bloomberg.